Who To Contact

Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207

Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com

Clinical Trial ID: NCT04408638

A Phase III, Open-Label, Multicenter,Randomized Study Evaluating the Efficacy and Safety of Glofitamab in Combination with Gemcitabine Plus Oxaliplatin Versus Rituximab in Combination with Gemcitabine and Oxaliplatin in Patients with Relapsed/Refractory Diffuse Large BCell Lymphoma

Status

Open

Conditions

Other

Phases

III

Age Group

Adult

Main Investiagtor

Norkin, Maxim

Practice

Lymphoma

Scope

National

Participating Institutions

Baptist MD Anderson Cancer Center

Nct ID Number

NCT04408638

Secondary Trial ID Number

GO41944

Keywords

Treatment